<DOC>
	<DOC>NCT02120664</DOC>
	<brief_summary>This study is designed to demonstrate the conversion of florbetapir (18F) Positron Emission Tomography (PET) Standard Uptake Value ratio (SUVr) to Centiloid units.</brief_summary>
	<brief_title>Florbetapir Calibration to the Centiloid Scale</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Cognitively Normal Subjects Males or females ≥ 21 and ≤ 45 years of age Minimental state examination (MMSE) ≥ 29 Clinically Diagnosed AD Subject Males or females ≥ 50 years of age Meet clinical criteria for dementia due to probable AD MMSE ≥ 16 and ≤ 26 Possible AD Subject Males or females ≥ 50 years of age Meet clinical criteria for dementia due to possible AD MMSE ≥ 16 and ≤ 26 MCI Subject Males or females ≥ 60 years of age with cognitive impairment (not dementia) MMSE &gt;24 and &lt;29 At Risk Elderly Subject Cognitively normal males or females that are known ApoE4 carriers and ≥ 75 years of age MMSE ≥ 27 Have had or currently have a diagnosis of neurodegenerative disorders other than AD Have a current serious or unstable illness that could interfere with completion of the study Subject has a known brain lesion, pathology or traumatic brain injury Have received or participated in a trial with investigational medications in the past 30 days Have had a radiopharmaceutical imaging or treatment procedure within 7 days of study imaging session Females of childbearing potential who are not surgically sterile, not refraining from sexual activity or not using reliable methods of contraception</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>